Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: Is there a survival difference?

BJU International

Volumn 110, Issue 10, 2012, Pages 1471-1477

  Badalato, Gina M ^a   Gaya, Josep M ^b   Hruby, Gregory ^a   Patel, Trushar ^a   Kates, Max ^a   Sadeghi, Neda ^a   Benson, Mitchell C ^a   McKiernan, James M ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

bladder preservation; conservative management; high grade clinical T1 bladder cancer; immediate radical cystectomy

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOMODULATING AGENT;

AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADMINISTRATION, INTRAVESICAL; AGED; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 84868198326     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11116.x     Document Type: Article

References (26)

1. Chang SS, Cookson MS,. Non-muscle-invasive bladder cancer: the role of radical cystectomy. Urology 2005; 66: 917-22 (Pubitemid 41587132)
2. Soloway MS, Sofer M, Vaidya A,. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 2002; 167: 1573-83 (Pubitemid 34240678)
3. Brake M, Loertzer H, Horsch R, Keller H,. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol 2000; 163: 1697-701 (Pubitemid 30366716)
4. Pansadoro V, Emiliozzi P, Defidio L, et al,. Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results. J Urol 1995; 154: 2054-8
5. Nieder AM, Simon MA, Kim SS, et al,. Radical cystectomy after bacillus Calmette-Guerin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation. Urology 2006; 67: 737-41
6. Soloway MS, Hepps D, Katkoori D, et al,. Radical cystectomy for BCG failure: has the timing improved in recent years? BJU Int 2011; 108: 182-5
7. Herr HW, Sogani PC,. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 2001; 166: 1296-9 (Pubitemid 32862159)
8. Bianco FJ Jr, Justa D, Grignon DJ, et al,. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004; 22: 290-4 (Pubitemid 38996784)
9. Wiesner C, Pfitzenmaier J, Faldum A, et al,. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 2005; 95: 301-5 (Pubitemid 40283112)
10. Badalato G, Patel T, Hruby G, et al,. Does the presence of muscularis propria on transurethral resection of bladder tumour specimens affect the rate of upstaging in cT1 bladder cancer? BJU Int 2011; 108: 1292-6
11. Guzzo TJ, Magheli A, Bivalacqua TJ, et al,. Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. Urology 2009; 74: 1276-80
12. Kulkarni GS, Urbach DR, Austin PC, et al,. Longer wait times increase overall mortality in patients with bladder cancer. J Urol 2009; 182: 1318-24
13. Lambert EH, Pierorazio PM, Olsson CA, et al,. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int 2007; 100: 33-6 (Pubitemid 46878562)
14. Hautmann RE, Volkmer BG, Gust K,. Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3). World J Urol 2009; 27: 347-51
15. Jakse G, Loidl W, Seeber G, et al,. Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 1987; 137: 39-43 (Pubitemid 17214219)
16. Stockle M, Alken P, Engelmann U, et al,. Radical cystectomy-often too late? Eur Urol 1987; 13: 361-7
17. Babjuk M, Oosterlinck W, Sylvester R, et al,. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008; 54: 303-14
18. Kolozsy Z,. Histopathological 'self control' in transurethral resection of bladder tumours. Br J Urol 1991; 67: 162-4
19. Jesuraj MG, Harris M, Rogers A, et al,. Completeness of first resection of bladder tumor depending on seniority of the surgeon. Eur Urol 2008; 7 (Suppl. 7): 138
20. Mariappan P, Zachou A, Grigor K,. Detrusor muscle in the first transurethral resection of bladder tumor (TURBT) specimen is a surrogate marker of resection quality and is dependant on operator experience. Eur Urol 2008; 57 (Suppl. 7): 843-9
21. Quek ML, Stein JP, Nichols PW, et al,. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 2005; 174: 103-6 (Pubitemid 40825683)
22. Streeper NM, Simons CM, Konety BR, et al,. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int 2009; 103: 475-9
23. Lotan Y, Gupta A, Shariat SF, et al,. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005; 23: 6533-9 (Pubitemid 46190245)
24. May M, Bastian PJ, Brookman-May S, et al,. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scand J Urol Nephrol 2011; 45: 251-7
25. Cho KS, Seo HK, Joung JY, et al,. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer. J Urol 2009; 182: 2625-30
26. De Berardinis E, Busetto G, Antonini G, et al,. T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy. Int Urol Nephrol 2011; 43: 1047-57